6W0O

Amyloid-beta(1-40) fibril derived from Alzheimer's disease cortical tissue

6W0O の概要

• エントリーDOI: 10.2210/pdb6w0o/pdb
• EMDBエントリー: 21501
• NMR情報: BMRB: 30731
• 分子名称: Amyloid-beta precursor protein (1 entity in total)
• 機能のキーワード: amyloid-beta, alzheimer's disease, protein fibril
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 6
• 化学式量合計: 26015.11

構造登録者

Ghosh, U.,Thurber, K.R.,Tycko, R. (登録日: 2020-03-02, 公開日: 2021-01-13, 最終更新日: 2024-05-15)

主引用文献

Ghosh, U.,Thurber, K.R.,Yau, W.M.,Tycko, R.
Molecular structure of a prevalent amyloid-beta fibril polymorph from Alzheimer's disease brain tissue.
Proc.Natl.Acad.Sci.USA, 118:-, 2021

PubMed Abstract: Amyloid-β (Aβ) fibrils exhibit self-propagating, molecular-level polymorphisms that may contribute to variations in clinical and pathological characteristics of Alzheimer's disease (AD). We report the molecular structure of a specific fibril polymorph, formed by 40-residue Aβ peptides (Aβ40), that is derived from cortical tissue of an AD patient by seeded fibril growth. The structure is determined from cryogenic electron microscopy (cryoEM) images, supplemented by mass-per-length (MPL) measurements and solid-state NMR (ssNMR) data. Previous ssNMR studies with multiple AD patients had identified this polymorph as the most prevalent brain-derived Aβ40 fibril polymorph from typical AD patients. The structure, which has 2.8-Å resolution according to standard criteria, differs qualitatively from all previously described Aβ fibril structures, both in its molecular conformations and its organization of cross-β subunits. Unique features include twofold screw symmetry about the fibril growth axis, despite an MPL value that indicates three Aβ40 molecules per 4.8-Å β-sheet spacing, a four-layered architecture, and fully extended conformations for molecules in the central two cross-β layers. The cryoEM density, ssNMR data, and MPL data are consistent with β-hairpin conformations for molecules in the outer cross-β layers. Knowledge of this brain-derived fibril structure may contribute to the development of structure-specific amyloid imaging agents and aggregation inhibitors with greater diagnostic and therapeutic utility.

PubMed: 33431654
DOI: 10.1073/pnas.2023089118

実験手法

ELECTRON MICROSCOPY (2.77 Å)
SOLID-STATE NMR (2.77 Å)